Search clinical trials for: SARS-CoV-2 recombinant spike protein Advax-SM adjuvant
Total 111 results
-
NovavaxActive, not recruiting
-
Laboratorio Avi-Mex, S.A. de C.V.National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...CompletedSARS-CoV-2 InfectionMexico
-
NovavaxCompletedCOVID-19 | SARS-CoV-2 InfectionUnited Kingdom
-
Bio-Thera SolutionsCompleted
-
Fred Hutchinson Cancer CenterNational Marrow Donor Program; Vir Biotechnology, Inc.TerminatedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of Rome Tor VergataCompletedLiver Transplantation | SARS-CoV-2 VaccinationItaly
-
NovavaxCompleted
-
Genexine, Inc.Active, not recruitingSARS-CoV-2Korea, Republic of
-
National Institute of Allergy and Infectious Diseases...Withdrawn
-
Jiangsu Province Centers for Disease Control and...Academy of Military Medical Sciences，Academy of Military Sciences，PLA; ZHONGYIANKE... and other collaboratorsRecruiting
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Parker Institute for Cancer ImmunotherapyActive, not recruitingAdvanced SarcomaUnited States
-
Jiangsu Province Centers for Disease Control and...West China HospitalCompleted
-
NovavaxCompletedCovid19 | SARS-CoV InfectionAustralia
-
University Hospital TuebingenDeutsche Kinderkrebsstiftung; Gesellschaft fur Padiatrische Onkologie und Hamatologie... and other collaboratorsCompletedSoft Tissue SarcomaGermany, Switzerland, Austria, Poland, Sweden
-
National Institute of Allergy and Infectious Diseases...Completed
-
Tuberculosis Research Centre, IndiaInternational Union Against Tuberculosis and Lung Diseases; Sarvodaya Charitable... and other collaboratorsActive, not recruitingPre-Extensively Drug-Resistant Pulmonary TB | Treatment Intolerant Multidrug-Resistant Pulmonary TB | Non-responsive Multidrug-Resistant Pulmonary TBIndia
-
National Cancer Institute (NCI)Completed
-
Northwestern UniversityFoundation for Sarcoidosis ResearchRecruitingSARS-CoV2 Infection | Sarcoidosis | Vaccine Response ImpairedUnited States
-
Hellenic Cooperative Oncology GroupCompleted
-
Diwakar DavarMerck Sharp & Dohme LLC; Gateway for Cancer ResearchNot yet recruitingPD-1 Refractory Advanced MelanomaUnited States
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
NovavaxNot yet recruiting
-
Zhejiang Cancer HospitalNot yet recruiting
-
New Valley UniversityNot yet recruiting
-
Canadian Immunization Research NetworkMassachusetts General Hospital; CHU de Quebec-Universite Laval; McGill University... and other collaboratorsActive, not recruiting
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingLiver Cancer | Liver TransplantChina
-
Chulalongkorn UniversityCompletedPeritonitisThailand
-
National Cancer Institute (NCI)Completed
-
Wei ZhaoCancer Institute and Hospital, Chinese Academy of Medical SciencesUnknownHematological NeoplasmsChina
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Not yet recruitingMetastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IV Colon Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8United States
-
GlaxoSmithKlineCompleted
-
Janssen Research & Development, LLCCompleted
-
Jonsson Comprehensive Cancer CenterCalifornia Institute for Regenerative Medicine (CIRM)TerminatedSarcoma | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | HLA-A*0201 Positive Cells Present | NY-ESO-1 PositiveUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
CelgeneCompleted
-
University of WashingtonNational Cancer Institute (NCI); BayerCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | de Novo Myelodysplastic Syndrome | Acute Biphenotypic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeuroendocrine Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Myeloid Leukemia With BCR-ABL1United States
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
Fred Hutchinson Cancer CenterTerminatedGlioblastoma | GliosarcomaUnited States